<code id='0AECAC755D'></code><style id='0AECAC755D'></style>
    • <acronym id='0AECAC755D'></acronym>
      <center id='0AECAC755D'><center id='0AECAC755D'><tfoot id='0AECAC755D'></tfoot></center><abbr id='0AECAC755D'><dir id='0AECAC755D'><tfoot id='0AECAC755D'></tfoot><noframes id='0AECAC755D'>

    • <optgroup id='0AECAC755D'><strike id='0AECAC755D'><sup id='0AECAC755D'></sup></strike><code id='0AECAC755D'></code></optgroup>
        1. <b id='0AECAC755D'><label id='0AECAC755D'><select id='0AECAC755D'><dt id='0AECAC755D'><span id='0AECAC755D'></span></dt></select></label></b><u id='0AECAC755D'></u>
          <i id='0AECAC755D'><strike id='0AECAC755D'><tt id='0AECAC755D'><pre id='0AECAC755D'></pre></tt></strike></i>

          knowledge

          knowledge

          author:entertainment    Page View:5212
          Mitch McConnell, after the 81-year-old GOP leader froze at the microphones as he arrived for a news conference, at the Capitol in Washington. -- health coverage from STAT
          J. Scott Applewhite/AP

          The handling of Senate Minority Leader Mitch McConnell’s abrupt medical issue this week is raising concerns among medical experts that the event sent a potentially dangerous public-health message — that when someone experiences an episode with symptoms like McConnell’s, they can simply return to work as though nothing had happened.

          McConnell experienced the episode on Wednesday — freezing and remaining silent for about 20 seconds during a press conference, then showing signs of disorientation — and was led away by aides while cameras rolled.

          advertisement

          Minutes later, the Kentucky senator, 81, returned to the press briefing and said, “I’m fine.” He didn’t answer specific questions about whether he was examined by a doctor. A McConnell aide later said the senator had felt light-headed.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Health insurers say they are turning to AI to cut costs, improve care
          Health insurers say they are turning to AI to cut costs, improve care

          AdobeHealthinsurersaretellingshareholdersthattheyarerampinguptheuseofartificialintelligenceandarehir

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Merck to buy EyeBio, maker of eye drug, as it grows pipeline

          AdobeLONDON—MercksaidWednesdayitisbuyingophthalmology-focusedstartupEyeBioinadealworthupto$3billion,